[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
[18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 5, Pages 145
Publisher
MDPI AG
Online
2018-05-21
DOI
10.3390/cancers10050145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial
- (2018) Anne-Ségolène Cottereau et al. BLOOD
- Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
- (2018) Andrea Gallamini et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
- (2017) Marc P.E. André et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study
- (2017) Colette Zwarthoed et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti–Programmed Death 1 Immune Checkpoint Inhibitor
- (2017) Laurent Dercle et al. JOURNAL OF NUCLEAR MEDICINE
- Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP escalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group
- (2017) Peter Borchmann et al. LANCET ONCOLOGY
- Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
- (2016) Bruce D. Cheson et al. BLOOD
- US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816
- (2016) Oliver W. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic Tumor Volume: We Still Need a Platinum-Standard Metric
- (2016) Andrea Gallamini et al. JOURNAL OF NUCLEAR MEDICINE
- Current and future immunotherapeutic approaches in Hodgkin lymphoma
- (2016) Paul J. Bröckelmann et al. LEUKEMIA & LYMPHOMA
- Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
- (2016) Peter Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma
- (2015) John Radford et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma
- (2014) Salim Kanoun et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
- (2014) A. Gallamini et al. HAEMATOLOGICA
- Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
- (2014) John M.M. Raemaekers et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
- (2013) A. Biggi et al. JOURNAL OF NUCLEAR MEDICINE
- Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma
- (2012) Tarec Christoffer El-Galaly et al. JOURNAL OF CLINICAL ONCOLOGY
- Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials
- (2012) Karolin Behringer et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
- (2012) Andreas Engert et al. LANCET
- Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients
- (2011) Pier Luigi Zinzani et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of Functional Imaging in the Management of Lymphoma
- (2011) Bruce D. Cheson JOURNAL OF CLINICAL ONCOLOGY
- Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
- (2010) Andrea Gallamini et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cost Effectiveness of Positron Emission Tomography in Patients With Hodgkin's Lymphoma in Unconfirmed Complete Remission or Partial Remission After First-Line Therapy
- (2010) Juliano J. Cerci et al. JOURNAL OF CLINICAL ONCOLOGY
- Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study
- (2009) Andreas Engert et al. JOURNAL OF CLINICAL ONCOLOGY
- Report on the First International Workshop on interim-PET scan in lymphoma
- (2009) Michel Meignan et al. LEUKEMIA & LYMPHOMA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now